Eesti - eesti - Ravimiamet

portfarma ehf. - nebivolool - tablett - 5mg 14tk; 5mg 56tk; 5mg 60tk; 5mg 100tk; 5mg 30tk; 5mg 98tk; 5mg 28tk

Eesti - eesti - Ravimiamet

pharmaswiss ceska republika s.r.o. - aripiprasool - suus dispergeeruv tablett - 15mg 56tk; 15mg 28tk

Eesti - eesti - Ravimiamet

v.m.d. - amoksitsilliin - pulber joogivees manustamiseks - 500mg 1g 1000g 1tk

Eesti - eesti - Ravimiamet

pharmaswiss ceska republika s.r.o. - aripiprasool - suus dispergeeruv tablett - 10mg 56tk

Eesti - eesti - Ravimiamet

bionorica se - maasapiürt+leeskputkejuur+rosmariinileht - kaetud tablett - 18mg+18mg+18mg 120tk; 18mg+18mg+18mg 60tk

Eesti - eesti - Ravimiamet

galderma international - ivermektiin - kreem - 10mg 1g 30g 1tk; 10mg 1g 60g 1tk; 10mg 1g 45g 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentaan - hüpertensioon, kopsuvähk - antihypertensives, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Eesti - eesti - Ravimiamet

medochemie limited - beetahistiin - tablett - 16mg 48tk; 16mg 50tk; 16mg 90tk; 16mg 24tk; 16mg 96tk; 16mg 100tk; 16mg 60tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - febuksostaat - õhukese polümeerikattega tablett - 120mg 84tk; 120mg 42tk; 120mg 98tk; 120mg 28tk; 120mg 14tk

Eesti - eesti - Ravimiamet

medochemie limited - beetahistiin - tablett - 8mg 90tk; 8mg 30tk; 8mg 100tk; 8mg 48tk; 8mg 24tk; 8mg 96tk; 8mg 50tk